Hepatitis B surface antibody (often abbreviated as HBsAb or anti-HBs) is a protein your immune system produces in response to the hepatitis B virus. Finding it in your blood generally means one thing: you’re immune to hepatitis B, either because you were vaccinated or because you recovered from a past infection. A level of 11 mIU/mL or higher is typically considered positive, indicating protective immunity.
What This Antibody Actually Does
When your body encounters the hepatitis B virus, either through infection or vaccination, your immune system learns to recognize the outer shell (surface) of the virus and builds antibodies that target it. These surface antibodies work by latching onto viral particles in your bloodstream and blocking them from entering liver cells. Specifically, they interfere with the virus’s ability to attach to receptors on liver cells, essentially neutralizing it before it can cause damage.
Surface antibodies also trigger other immune responses. Once bound to the virus, they can flag infected cells for destruction by other immune cells or activate a process that punches holes in those cells. This combination of neutralizing free-floating virus and helping clear infected cells is why the presence of this antibody is considered the hallmark of protective immunity.
Interpreting Your Test Results
Your lab report will show one of three results:
- Positive (reactive): Anti-HBs detected at 11 mIU/mL or above. This means you have protective immunity against hepatitis B.
- Indeterminate: A low level of antibody detected, but not enough to confirm immunity. This sometimes prompts a retest or an additional vaccine dose.
- Negative (non-reactive): No surface antibody detected. You are not immune to hepatitis B.
A positive result on its own doesn’t tell you whether your immunity came from vaccination or from fighting off a natural infection. To distinguish between the two, labs look at another marker called the hepatitis B core antibody (anti-HBc). If your surface antibody is positive but your core antibody is negative, your immunity came from vaccination. If both are positive, you recovered from a past infection. Either way, you’re protected and cannot pass the virus to others.
When and Why This Test Is Ordered
The most common reason to check your surface antibody level is to confirm that your hepatitis B vaccine actually worked. The recommended timing is 4 to 8 weeks after completing the full vaccine series. Testing too soon after the last dose may not give your immune system enough time to build a measurable response.
This test is also part of the standard hepatitis B diagnostic panel, which includes the surface antigen (HBsAg) and core antibody tests. Together, these three markers create a picture of whether you’re currently infected, immune, or still vulnerable. Healthcare workers, people born in regions where hepatitis B is common, and anyone starting treatment that suppresses the immune system are among those frequently tested.
What If Your Result Is Negative
A negative result after vaccination doesn’t necessarily mean the vaccine failed permanently. About 5 to 10% of healthy adults don’t produce enough antibodies after the standard three-dose series. Several factors raise the risk of non-response: older age, obesity, smoking, diabetes, and chronic kidney disease. The non-response rate climbs much higher in people with weakened immune systems. Among those with HIV, for example, 44 to 76% may not respond adequately, and the rate in celiac disease patients can reach 50 to 70%.
If you tested negative, your provider may recommend repeating the full vaccine series and retesting. Many non-responders do develop immunity after a second round. Newer vaccine formulations using different immune-boosting ingredients have also improved response rates in people who didn’t respond the first time.
Antibody Levels Can Fade Over Time
It’s normal for surface antibody levels to decline years after vaccination. This doesn’t necessarily mean you’ve lost protection. Your immune system retains memory cells that can rapidly produce new antibodies if you’re ever exposed to the virus. The CDC notes that people who completed a documented vaccine series and responded at the time generally do not need booster doses, even if their antibody levels later test below the protective threshold.
There are exceptions. Patients on hemodialysis and healthcare personnel with ongoing exposure risk may need periodic retesting and booster doses if their levels drop. For most other people, a past positive response to the vaccine is considered sufficient proof of lasting immunity.
The Window Period in Natural Infection
During an acute hepatitis B infection, the body’s immune markers appear in a specific sequence. The surface antigen (a piece of the virus itself) shows up first, within 2 to 10 weeks of exposure. Core antibodies follow about two weeks later. In people who successfully clear the virus, the surface antigen disappears within six months, and the surface antibody appears afterward, marking recovery.
There’s a brief gap between when the surface antigen disappears and the surface antibody becomes detectable. During this “window period,” neither marker shows up on blood tests, which can make diagnosis tricky. The core antibody is the only positive marker during this phase, which is one reason it’s included in standard hepatitis B testing panels.